- Home
- ASPI vs CCAP Comparison
ASPI vs CCAP Comparison
Compare ASPI & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- CCAP
- Stock Information
- Founded
- ASPI 2021
- CCAP 2015
- Country
- ASPI United States
- CCAP United States
- Employees
- ASPI N/A
- CCAP N/A
- Industry
- ASPI Major Chemicals
- CCAP Finance: Consumer Services
- Sector
- ASPI Industrials
- CCAP Finance
- Exchange
- ASPI Nasdaq
- CCAP Nasdaq
- Market Cap
- ASPI 653.4M
- CCAP 582.2M
- IPO Year
- ASPI 2022
- CCAP N/A
- Fundamental
- Price
- ASPI $8.21
- CCAP $15.94
- Analyst Decision
- ASPI Strong Buy
- CCAP Buy
- Analyst Count
- ASPI 1
- CCAP 4
- Target Price
- ASPI $11.00
- CCAP $16.38
- AVG Volume (30 Days)
- ASPI 5.2M
- CCAP 216.4K
- Earning Date
- ASPI 08-14-2025
- CCAP 08-13-2025
- Dividend Yield
- ASPI N/A
- CCAP 10.85%
- EPS Growth
- ASPI N/A
- CCAP N/A
- EPS
- ASPI N/A
- CCAP 1.19
- Revenue
- ASPI $4,581,523.00
- CCAP $183,172,000.00
- Revenue This Year
- ASPI $512.64
- CCAP N/A
- Revenue Next Year
- ASPI $181.15
- CCAP $1.65
- P/E Ratio
- ASPI N/A
- CCAP $13.43
- Revenue Growth
- ASPI 99.57
- CCAP N/A
- 52 Week Low
- ASPI $2.11
- CCAP $13.54
- 52 Week High
- ASPI $11.68
- CCAP $20.19
- Technical
- Relative Strength Index (RSI)
- ASPI 41.60
- CCAP 75.62
- Support Level
- ASPI $8.35
- CCAP $15.46
- Resistance Level
- ASPI $10.87
- CCAP $15.38
- Average True Range (ATR)
- ASPI 0.71
- CCAP 0.21
- MACD
- ASPI -0.25
- CCAP 0.06
- Stochastic Oscillator
- ASPI 16.19
- CCAP 90.82
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About CCAP Crescent Capital BDC Inc. Common stock
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.